We have a fully developed healthcare, pharmaceuticals and life sciences practice. Many of our specialist lawyers have scientific backgrounds and have worked in the industry for many years, so we are able to offer clients a genuine interest and understanding of the sector combined with integrated and expert advice on the law.

Our services include:

  • regulatory support (clinical trial agreements, regulatory approval process, reviewing developments, strategies to counteract parallel imports, getting clearance for borderline products and challenging regulatory bodies);
  • intellectual property (such as brand protection, IP ownership, internet activities and patent management);
  • environmental (including manufacturing consents, health and safety, product liability and environmental risk, toxic tort claims and corporate social responsibility);
  • M&As, joint ventures and partnership agreements; and
  • antitrust, competition and trade (including merger control, licensing and distribution, intellectual property, restrictive practices, market dominance, state aid, cartel investigations, free movement, public procurement and trade including World Trade Organisation matters).

Our clients include pharmaceuticals, biotechnology, medical devices, pharmaceuticals distribution companies and other parties, such as regulatory authorities and academic institutions. We advise on the wide range of issues, whether involving legacy products or cutting-edge research and product development, affecting this highly regulated industry.

Our success is due to the strength and depth of our team, which encompasses lawyers from our corporate, antitrust, intellectual property, regulatory, and product liability teams. We are able to provide clients with a multijurisdictional capability in these practice areas across Europe.

For more information please contact Sasha McPherson, business development executive.

News

Fewer corporate insolvencies but company voluntary arrangements rise by almost 50% and real estate and construction account for more than half of larger cases View

Freshfields elects nine to counsel role View

Briefings

Life sciences: China  View

Class actions in the EU: a threat to the life sciences industry?  View

Awards

Life Sciences Law Firm of the Year - FT/Mergermarket M&A Awards (2007)

View all awards

Contact